We are live on ! Find out more
ACUR

Acura Pharmaceuticals
ACUR

Delisted

ACUR was delisted on the 22nd of February, 2017.

33 hedge funds and large institutions have $12.6M invested in Acura Pharmaceuticals in 2014 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 4 increasing their positions, 9 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

11% less funds holding

Funds holding: 3733 (-4)

26% less capital invested

Capital invested by funds: $17.1M → $12.6M (-$4.47M)

29% less call options, than puts

Call options by funds: $10K | Put options by funds: $14K

44% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 9

56% less repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 9

Holders
33
Holders Change
-4
Holders Change %
-10.81%
% of All Funds
0.95%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
5
Increased
4
Reduced
9
Closed
9
Calls
$10K
Puts
$14K
Net Calls
-$4K
Net Calls Change
-$16K

ACUR Hedge Fund Activity: Q2 2014 in Review

33 of the 3,480 institutional investors tracked by Wall St. Rank reported a position in Acura Pharmaceuticals (ACUR) for Q2 2014, worth a combined $12.6M — down 26% from $17.1M a quarter earlier.

Sellers outnumbered buyers: 9 funds closed out of ACUR and 5 opened new positions — a net loss of 4 holders — while 9 trimmed existing stakes and 4 added.

The largest buyer was Creative Planning, opening a new position worth an estimated $128K. The largest seller was Commerce Bank, exiting entirely with an estimated $131K sold.

  • 33 institutional investors held Acura Pharmaceuticals (ACUR) as of Q2 2014, down from 37 in Q1 2014.
  • Funds reported $12.6M of Acura Pharmaceuticals stock for Q2 2014, down 26% quarter-over-quarter.
  • 5 funds opened new Acura Pharmaceuticals positions in Q2 2014 and 9 closed out, a net change of -4 holders.
  • The largest Acura Pharmaceuticals buyer in Q2 2014 was Creative Planning, an estimated $128K added.
  • The largest Acura Pharmaceuticals seller in Q2 2014 was Commerce Bank, an estimated $131K sold.

Based on aggregated 13F filings for Q2 2014.